Cardiol Therapeutics Inc
Cardiol Therapeutics Inc (CRDL) Option Chain
As of September 21, 2026, Cardiol Therapeutics Inc is trading at $1.89, a +1.35% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 81.8%. IV Rank is 16%.
Read more
Tracking the CRDL option chain helps you see every strike and expiry on Cardiol Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Cardiol Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of CRDL options activity at a glance. Use our scanner to monitor the CRDL option chain in real time and filter for the CRDL options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For CRDL stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the CRDL option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where CRDL stock options are being actively traded and where they are not.
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx as a cardioprotective therapy to reduce cardiovascular and respiratory events in patients hospitalized with COVID-19, as well as to evaluate the efficacy and safety of CardiolRx in acute myocarditis. The company is also developing subcutaneous formulation of CardiolRx for the treatment of fibrosis and inflammation in the heart that is related with the development and progression of heart failure.
Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Cardiol Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen CRDL options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of CRDL stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryDrug Manufacturers - Specialty & Generic
- SectorHealthcare
- IV percentile15.48% Subdued
- Market cap (M$)217
- 52 weeks high-20.51%
- 52 weeks low111.36%
- Analyst recommendationStrong Buy
1.00 - Target price$8.50
350.93% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-12
- P/E—
- Future P/E—
- EPS (ttm)-0.25
- EPS growth next 5 years79.41%
As of September 21, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 93.09 | 82 | 121 | 0.08 | 0.00 | 0.05 | 0.10 | 2.50 | +34.41 | — | 1.20 | 0.61 | 0.59 | 0 | 0 | 6.91 |
| 100.00 | 5 | 0 | 0.70 | 0.00 | — | 0.70 | 5.00 | +168.82 | 0.70 | 5.50 | 3.11 | -0.01 | 0 | 0 | 0.00 |
| 100.00 | 0 | 0 | 2.55 | 0.00 | — | 2.55 | 7.50 | +303.23 | 3.20 | 8.00 | 5.61 | -0.01 | 0 | 0 | 0.00 |
As of September 21, 2026
Scan the full option chain in one place
Browse the full CRDL option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→